Holen Sie sich die Stockscreener-App
100.25
0.70%
-0.71
Vorhandelsmarkt:
102.00
1.75
+1.75%
Schlusskurs vom Vortag:
$100.96
Offen:
$100.55
24-Stunden-Volumen:
149.30K
Relative Volume:
1.32
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.12%
1M Leistung:
+8.16%
6M Leistung:
+18.48%
1J Leistung:
+50.57%
1-Tages-Spanne:
$99.31
$100.95
1-Wochen-Bereich:
$97.84
$100.96
52-Wochen-Spanne:
$64.94
$100.96
Ishares U S Pharmaceuticals Etf Stock (IHE) Company Profile
Firmenname
Ishares U S Pharmaceuticals Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare IHE vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IHE
Ishares U S Pharmaceuticals Etf
|
100.25 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
371.67 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
751.28 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
754.76 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
301.66 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
722.82 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares U S Pharmaceuticals Etf Aktie (IHE) Neueste Nachrichten
Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? - Yahoo Finance
iShares U.S. Pharmaceuticals ETF (IHE) Stock Price Quote Today & Current Price Chart - Capital.com
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? - AOL.com
IShares TrustiShares U.S. Pharmaceuticals ETF announces Quarterly dividend, payable on June 18, 2026 - marketscreener.com
Ditch or double down on this pharma ETF as Trump adjusts drug prices? - MSN
Even if Eli Lilly stock continues to shine, stay away from this pharmaceutical ETF - MSN
Axsome Therapeutics Inc (AXSM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Prestige Consumer Healthcare Inc (PBH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Crinetics Pharmaceuticals Inc (CRNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Evolus Inc (EOLS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Royalty Pharma PLC (RPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amylyx Pharmaceuticals Inc (AMLX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ligand Pharmaceuticals Inc (LGND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Elanco Animal Health Inc (ELAN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LENZ Therapeutics Inc (LENZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Johnson & Johnson (JNJ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avadel Pharmaceuticals PLC (AVDL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Enliven Therapeutics Inc (ELVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arvinas Inc (ARVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amneal Pharmaceuticals Inc (AMRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Zoetis Inc (ZTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Phathom Pharmaceuticals Inc (PHAT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Tarsus Pharmaceuticals Inc (TARS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nuvation Bio Inc (NUVB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Eli Lilly and Co (LLY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Supernus Pharmaceuticals Inc (SUPN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Trump Administration Prepares Up To 100% Pharma Tariffs On Drugs From Companies That Have Not Struck A Deal Yet: Report - Stocktwits
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - AOL.com
Healthcare ETFs: From Broad Exposure to Big Breakthroughs - ETF Database
The iShares U.S. Pharmaceutical ETF Has Achieved a Return of Over 42% in the Past Year - NAI500
iShares vs Simplify Health Care ETFs: A Comparison of Two Healthcare Funds - IndexBox
iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns - The Motley Fool
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market - TradingView
IXUS vs. IEFA: Which International ETF Is Better for Most Investors? - The Motley Fool
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike - The Globe and Mail
Pharma stocks are showing strength. Charts predict this name could break out next - CNBC
iShares MSCI World ETF Faces a Crucible of Rate Fears, a Dividend Date, and a Landmark Space IPO - AD HOC NEWS
Sector Update: Healthcare - Moomoo
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance
Flow Focus | Marvell Ripped, Broadcom Cracked — AI Money Is Getting Pickier - Moomoo
MSCI World ETF Caught Between a Mega-IPO and a Narrowing Market - AD HOC NEWS
The Technical Signals Behind (IHE) That Institutions Follow - Stock Traders Daily
iShares MSCI World ETF Faces a Congested June Calendar: Dividend, Fed Decision, and Tariff Fallout - AD HOC NEWS
The $12 Billion Index Mechanic: Why the MSCI World ETF Cannot Dodge SpaceX’s Mega-IPO - AD HOC NEWS
MACD Signal Flashes Bullish for MSCI World ETF, but Pharma Tariffs and SpaceX Add to the Risk Stack - AD HOC NEWS
ETF Diversification and IHE Analysis - asatunews.co.id
The iShares MSCI World ETF: A Record High Surrounded by a Thicket of Risks - AD HOC NEWS
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - Yahoo Finance
Finanzdaten der Ishares U S Pharmaceuticals Etf-Aktie (IHE)
Es liegen keine Finanzdaten für Ishares U S Pharmaceuticals Etf (IHE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):